Huang, X.; Kaneda-Nakashima, K.; Kadonaga, Y.; Kabayama, K.; Shimoyama, A.; Ooe, K.; Kato, H.; Toyoshima, A.; Shinohara, A.; Haba, H.;
et al. Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection. Pharmaceutics 2022, 14, 2705.
https://doi.org/10.3390/pharmaceutics14122705
AMA Style
Huang X, Kaneda-Nakashima K, Kadonaga Y, Kabayama K, Shimoyama A, Ooe K, Kato H, Toyoshima A, Shinohara A, Haba H,
et al. Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection. Pharmaceutics. 2022; 14(12):2705.
https://doi.org/10.3390/pharmaceutics14122705
Chicago/Turabian Style
Huang, Xuhao, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, Kazuya Kabayama, Atsushi Shimoyama, Kazuhiro Ooe, Hiroki Kato, Atsushi Toyoshima, Atsushi Shinohara, Hiromitsu Haba,
and et al. 2022. "Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection" Pharmaceutics 14, no. 12: 2705.
https://doi.org/10.3390/pharmaceutics14122705
APA Style
Huang, X., Kaneda-Nakashima, K., Kadonaga, Y., Kabayama, K., Shimoyama, A., Ooe, K., Kato, H., Toyoshima, A., Shinohara, A., Haba, H., Wang, Y., & Fukase, K.
(2022). Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection. Pharmaceutics, 14(12), 2705.
https://doi.org/10.3390/pharmaceutics14122705